Mark Alan Goldberg - Mar 29, 2024 Form 4 Insider Report for GLYCOMIMETICS INC (GLYC)

Role
Director
Signature
/s/ Brian F. Leaf, Attorney-in-Fact
Stock symbol
GLYC
Transactions as of
Mar 29, 2024
Transactions value $
$13,752
Form type
4
Date filed
4/2/2024, 04:05 PM
Previous filing
Feb 12, 2024
Next filing
May 1, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GLYC Common Stock Award $13.8K +4.58K +22.64% $3.00 24.8K Mar 29, 2024 Direct F1
holding GLYC Common Stock 11.5K Mar 29, 2024 By family trusts
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares will be issued to the reporting person pursuant to the issuer's non-employee director compensation policy in lieu of board and committee retainer fees of $13,750.